Review: taking Metronidazole and Cyclobenzaprine hydrochloride together


Summary

Drug interactions are reported among people who take Metronidazole and Cyclobenzaprine hydrochloride together. This review analyzes the effectiveness and drug interactions between Metronidazole and Cyclobenzaprine hydrochloride. It is created by eHealthMe based on reports of 607 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metronidazole and Cyclobenzaprine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metronidazole

Metronidazole has active ingredients of metronidazole. It is often used in infection. (latest outcomes from Metronidazole 15,589 users)

Cyclobenzaprine Hydrochloride

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. (latest outcomes from Cyclobenzaprine hydrochloride 2,643 users)

On Aug, 24, 2016

607 people who take Metronidazole, Cyclobenzaprine Hydrochloride are studied.


Number of reports submitted per year:

Metronidazole and Cyclobenzaprine hydrochloride drug interactions.

Drug effectiveness over time:

Metronidazole:
  • < 1 month: 40.0% - (2 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Cyclobenzaprine Hydrochloride:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Metronidazole:
  • female: 16.0% - (1 of 6 people)
  • male: 100.0% - (2 of 2 people)
Cyclobenzaprine Hydrochloride:
  • female: 12.0% - (1 of 8 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Metronidazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Cyclobenzaprine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 0.0% - (0 of 3 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anal abscess
  • lymphoma
  • scrotal abscess
  • abdominal pain
  • vomiting
  • hypoaesthesia
  • muscle spasms
  • abdominal distension
  • alopecia
  • anxiety
1 - 6 months:
  • hypoaesthesia
  • neuropathy peripheral
  • paraesthesia
  • sweating increased
  • weight decreased
  • abnormal weight gain
  • agitation
  • anxiety disorder
  • blood pressure increased
  • breast cancer
6 - 12 months:
  • trichotillomania
2 - 5 years:
  • anxiety
  • depression
  • cholelithiasis
  • injury
  • suicide attempt
  • aphthous stomatitis
  • emotional distress
  • general physical health deterioration
  • impaired healing
  • intentional overdose
5 - 10 years:
  • anxiety
  • pain
  • back disorder
  • blood cholesterol increased
  • blood triglycerides increased
  • cerebral haemorrhage
  • chest pain
  • coronary artery disease
  • decreased activity
  • depression
not specified:
  • pain
  • anxiety
  • osteoarthritis
  • back pain
  • anaemia
  • osteonecrosis of jaw
  • injury
  • nausea
  • fatigue
  • depression

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • osteoarthritis
  • injury
  • back pain
  • osteonecrosis of jaw
  • anaemia
  • depression
  • diarrhoea
  • fatigue
male:
  • pain
  • anxiety
  • nausea
  • anaemia
  • pyrexia
  • back pain
  • arthralgia
  • bone disorder
  • osteonecrosis of jaw
  • pain in extremity

Most common drug interactions by age *:

2-9:
  • scar
  • acute sinusitis
  • anaemia
  • angiopathy
  • anhedonia
  • anxiety
  • aortic arteriosclerosis
  • arthropathy
  • back pain
  • bone disorder
10-19:
  • pre-eclampsia
  • abortion spontaneous
  • hypertension
  • migraine
  • ovarian cyst
  • thrombosis
  • asthma
  • cervical dysplasia
  • chest pain
  • drug exposure during pregnancy
20-29:
  • injury
  • vomiting
  • emotional distress
  • nausea
  • pain
  • anxiety
  • abdominal pain upper
  • pulmonary embolism
  • cholelithiasis
  • depression
30-39:
  • pain
  • injury
  • emotional distress
  • chest pain
  • fall
  • deep vein thrombosis
  • pulmonary embolism
  • pain in extremity
  • arthralgia
  • cough
40-49:
  • pain
  • back pain
  • bone disorder
  • impaired healing
  • dysphagia
  • osteonecrosis of jaw
  • arthralgia
  • anxiety
  • depression
  • pain in extremity
50-59:
  • pain
  • anaemia
  • osteoarthritis
  • anxiety
  • oedema peripheral
  • fatigue
  • osteonecrosis of jaw
  • intervertebral disc protrusion
  • depression
  • abdominal pain
60+:
  • pain
  • anxiety
  • osteoarthritis
  • dyspnoea
  • injury
  • osteomyelitis
  • diarrhoea
  • back pain
  • fall
  • osteonecrosis of jaw

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metronidazole and Cyclobenzaprine hydrochloride?

Can you answer these questions?

More questions for: Metronidazole, Cyclobenzaprine hydrochloride

You may be interested in these reviews

More reviews for: Metronidazole, Cyclobenzaprine hydrochloride

On eHealthMe, Metronidazole (metronidazole) is often used to treat infection. Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride) is often used to treat muscle spasms. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.